Zobrazeno 1 - 10
of 3 828
pro vyhledávání: '"juvenile dermatomyositis"'
Autor:
Jacob C. Spitznagle, Akadia Kacha-Ochana, Joan M. Cook-Mills, Gabrielle A. Morgan, Lauren M. Pachman
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract Background Juvenile dermatomyositis (JDM) is a systemic vasculopathy associated with metabolic derangements and possible increased risk for premature atherosclerosis. Oxidation of low-density lipoprotein (LDL) in the endothelium is an early
Externí odkaz:
https://doaj.org/article/986ecb24e1a24bf6b775cd8a8f13fe5b
Autor:
Sonia Carriquí-Arenas, Juan Manuel Mosquera, Estefanía Quesada-Masachs, Mireia López, Daniel Clemente, Alina Boteanu, Clara Udaondo, Jaime de Inocencio, Juan Carlos Nieto, Leyre Riancho, Esmeralda Núñez, Judith Sánchez-Manubens, María José Lirola, Rosa Roldán, Marisol Camacho, Melania Martínez, Marta Medrano, Paula Alcañiz, Jordi Antón, Estíbaliz Iglesias
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Juvenile Dermatomyositis (JDM) is the most common chronic idiopathic inflammatory myopathy in children. The diagnosis is clinical. Baseline laboratory and complementary studies trace the phenotype of these patients. The objective
Externí odkaz:
https://doaj.org/article/f81b686df4904b1e972b9cc5dca811bb
Autor:
Amer Khojah, Madeline Schutt, Gabrielle Morgan, Ameera Bukhari, Nicolas Bensen, Aaruni Khanolkar, Lauren M. Pachman
Publikováno v:
Clinical Immunology Communications, Vol 5, Iss , Pp 20-25 (2024)
This study investigates HLA-DR expression on activated T cells and serum neopterin levels in Juvenile Dermatomyositis (JDM) children pre- and post-treatment. Sixty-nine JDM children (less than 18 years) were included. Elevated HLA-DR+ T cells (>7 %)
Externí odkaz:
https://doaj.org/article/93727d4a8ec144cb81ec35aa79945c61
Autor:
Khalila Nainia, Mohamed Amine Aouzal, Imane Ouafik, Mariyam Charhbili, Amal Bouchhab, Abdellatif Daoudi, Samira Tizki, Radia Chakiri
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-5 (2024)
Abstract Background Juvenile Dermatomyositis (JDM) is the leading cause of non-infectious inflammatory myopathy in children. It is a heterogeneous group of autoimmune diseases characterized by a variable combination of muscular, dermatological, and v
Externí odkaz:
https://doaj.org/article/714efaecef674cb39629ec0c2d4aa358
Autor:
Susumu Yamazaki, Masaki Shimizu, Ayane Yakabe, Eisuke Inage, Keisuke Jimbo, Mitsuyoshi Suzuki, Futaba Miyaoka, Shuya Kaneko, Hitoshi Irabu, Asami Shimbo, Yoshiyuki Ohtomo, Masaaki Mori, Tomohiro Morio, Toshiaki Shimizu
Publikováno v:
Immunological Medicine, Vol 47, Iss 2, Pp 110-117 (2024)
AbstractAlthough the clinical efficacy of tofacitinib has been reported in adult patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (Ab+) dermatomyositis, data on its use in refractory juvenile dermatomyositis (JDM
Externí odkaz:
https://doaj.org/article/9f9970c3b01e4b01ab486a325509d0ab
Autor:
Yanyan Ling, Huaiqiang Hu, Xiangyan Xu, Jianli Feng, Mingzhe Li, Huan Li, Ming Cheng, Xiaoling Wang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundJuvenile dermatomyositis (JDM) is a rare autoimmune myopathy whose main clinical manifestations include a characteristic rash, symmetrical proximal muscle weakness, and elevated muscle enzymes. While approximately one-third of adult patient
Externí odkaz:
https://doaj.org/article/4c158cfec202447dbd5ebdb366af2d33
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Juvenile dermatomyositis (JDM) is a rare autoimmune disorder with multi-system involvement, often presenting with a heliotrope rash, Gottron's papules, and proximal muscle weakness. JDM patients with anti-nuclear matrix protein 2 (anti-NXP2) positivi
Externí odkaz:
https://doaj.org/article/2dd8662dca714b27bbcf747ce20641d8
Autor:
Reza Shiari, Mitra Khalili, Vahide Zeinali, Niloufar Shashaani, Mohammad Samami, Foroughossadat Hosseini Moghaddamemami
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Juvenile Dermatomyositis (JDM) is a rare autoimmune disorder that primarily affects muscles and skin. One of the severe complications associated with JDM is calcinosis, and treating this condition presents significant challenges.
Externí odkaz:
https://doaj.org/article/4e7be7b9753e4f7fa4991ab17ffda664
Publikováno v:
Indian Journal of Paediatric Dermatology, Vol 25, Iss 1, Pp 20-26 (2024)
Background: Connective tissue diseases (CTDs) are chronic in nature and carry a high risk of morbidity, disability, and mortality if not recognized and treated promptly. Data on clinical spectrum of CTDs in the pediatric age group are sparse from dev
Externí odkaz:
https://doaj.org/article/1fc32d0e01b941ed877dc6ead3d9a8c5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.